In the original article, the title was incorrectly written as “Case Report: 7-Ethyl-10-hydroxycamptothecin, a DNA topoisomerase I inhibitor, performs BRD4 inhibitory activity and inhibits human leukemic cell growth”.
The correct article title is “7-Ethyl-10-hydroxycamptothecin, a DNA topoisomerase I inhibitor, performs BRD4 inhibitory activity and inhibits human leukemic cell growth”.
The authors state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.